Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen)

Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers

(2013) Prasad S. Kulkarni et al.   VACCINE

Making rabies prophylaxis more economical

(2013) Guihua Huang et al.   Human Vaccines & Immunotherapeutics

Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: Results of a randomized, open label, active-controlled trial in healthy adult volunteers in India

(2012) Mysore Kalappa Sudarshan et al.   Human Vaccines & Immunotherapeutics

One in a million, or one in thousand: What is the morbidity of rabies in India?

(2012) Janie M. Baxter   Journal of Global Health

The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen

(2011) Huazhang Liu et al.   Human vaccines & immunotherapeutics

Rabies-Specific Antibodies: Measuring Surrogates of Protection against a Fatal Disease

(2010) Susan M. Moore et al.   PLoS Neglected Tropical Diseases

Rabies viral encephalitis: clinical determinants in diagnosis with special reference to paralytic form

(2009) G. Gadre et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals

(2009) Charles E. Rupprecht et al.   VACCINE

Rabies in India

(2008) R. Menezes   CANADIAN MEDICAL ASSOCIATION JOURNAL